Value of dynamic and DWI MRI in evaluation of HCC viability after TACE via LI-RADS v2018 diagnostic algorithm

被引:9
作者
Saleh, Tamer Yousef [1 ]
Bahig, Suzan [2 ]
Shebrya, Naglaa [2 ]
Ahmed, Aya Yassin [2 ]
机构
[1] Mil Med Acad, Heliopolis, Egypt
[2] Ain Shams Univ, Fac Med, Cairo, Egypt
关键词
HCC; TACE; DCE MRI; DWI; LI-RADS v2018 treatment response; DIFFUSION-WEIGHTED MRI; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; HEPATOCELLULAR-CARCINOMA; RECURRENCE;
D O I
10.1186/s43055-019-0120-x
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Detection of the value of DCE (dynamic contrast enhanced) MRI and DWI (diffusion-weighted imaging) in follow-up of treatment response for HCC (hepatocellular carcinoma) lesions post TACE (trans-arterial chemo-embolization) through LI-RADS v2018 algorithmic approach.ResultsA prospective study was performed on 30 patients with 41 treated hepatic focal lesions. The patients underwent DCE MRI with DWI in less than 1-month duration following TACE procedure and were radiologically assessed to observe tumoral post treatment response; then, another follow-up after another 3months later was done for non-viable, equivocal, and non-evaluable post treatment response categories. Statistical analysis showed that DCE MRI had 100% level of sensitivity, specificity of 95.24%, PPV of 95.00%, and NPV of 100% with an overall agreement of 97.50%. While on the other hand, statistics showed that DWI has 52.63% level of sensitivity, specificity of 90.48%, PPV of 83.33%, PPV of 67.86%, and NPV of 72.50%.The difference between non-viable and viable groups' ADC variables was found statistically significant at P value <0.001, and best cut off value that augments sensitivity and specificity is 1.35. At this ADC value, sensitivity reaches 78.9% and specificity is 85.7%.ConclusionsOur study showed that DCE MRI has 100% level of sensitivity via application of LI-RADS v2018 diagnostic algorithmic approach while DWI alone has 52.63% level of sensitivity, yet it can enhance the diagnostic confidence of DCE MRI for post treatment response viability detection.
引用
收藏
页数:11
相关论文
共 19 条
  • [1] Diffusion weighted magnetic resonance imaging in assessment of hepatocellular carcinoma after chemoembolization
    Afifi, A. H.
    Naguib, A. M.
    Seragaldin, F.
    [J]. EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2016, 47 (01) : 61 - 71
  • [2] Chan Y. H., 2003, SMJ Singapore Medical Journal, V44, P391
  • [3] Chan Y. H., 2003, SMJ Singapore Medical Journal, V44, P498
  • [4] Ebeed AE, 2017, EGYPT J RADIOL NUC M, V48, P807, DOI 10.1016/j.ejrnm.2017.06.006
  • [5] Subtraction MRI versus diffusion weighted imaging: Which is more accurate in assessment of hepatocellular carcinoma after Trans Arterial Chemoembolization (TACE)?
    ElSaid, Noha Abd ElShafy
    Kaddah, Randa Osama
    Fattah, Marwa Shaker Abdel
    Salama, Nada Mohsen
    [J]. EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2016, 47 (04) : 1251 - 1264
  • [6] 2017 Version of LI-RADS for CT and MR Imaging: An Update
    Elsayes, Khaled M.
    Hooker, Jonathan C.
    Agrons, Michelle M.
    Kielar, Ania Z.
    Tang, An
    Fowler, Kathryn J.
    Chernyak, Victoria
    Bashir, Mustafa R.
    Kono, Yuko
    Do, Richard K.
    Mitchell, Donald G.
    Kamaya, Aya
    Hecht, Elizabeth M.
    Sirlin, Claude B.
    [J]. RADIOGRAPHICS, 2017, 37 (07) : 1994 - 2017
  • [7] GALEN RS, 1980, PEDIATR CLIN N AM, V27, P861
  • [8] Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: Is diffusion-weighted MRI reliable as an indicator?
    Goshima, Satoshi
    Kanematsu, Masayuki
    Kondo, Hiroshi
    Yokoyama, Ryujiro
    Tsuge, Yusuke
    Shiratori, Yoshimune
    Onozuka, Minoru
    Moriyama, Noriyuki
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2008, 27 (04) : 834 - 839
  • [9] Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm
    Kielar, Ania
    Fowler, Kathryn J.
    Lewis, Sara
    Yaghmai, Vahid
    Miller, Frank H.
    Yarmohammadi, Hooman
    Kim, Charles
    Chernyak, Victoria
    Yokoo, Takeshi
    Meyer, Jeffrey
    Newton, Isabel
    Do, Richard K.
    [J]. ABDOMINAL RADIOLOGY, 2018, 43 (01) : 218 - 230
  • [10] Evaluation and Management of Hepatocellular Carcinoma
    Kulik, Laura M.
    Chokechanachaisakul, Attasit
    [J]. CLINICS IN LIVER DISEASE, 2015, 19 (01) : 23 - 43